Perry James Richard
Director
6 filings on record here, covering ET, TAK, FRMI, ROIV, HDSN, APRE. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-10
| Buy | ET | Energy Transfer LP | $250,000 |
CORPORATEFiled 2026-07-06
| Award | TAK | TAKEDA PHARMACEUTICAL CO LTD | |
CORPORATEFiled 2026-07-02
| Sell | FRMI | Fermi Inc. | $6,313,186 |
CORPORATEFiled 2026-06-23
| Tax | ROIV | Roivant Sciences Ltd. | $66,914 |
CORPORATEFiled 2026-06-22
| Award | HDSN | HUDSON TECHNOLOGIES INC /NY | |
CORPORATEFiled 2026-06-17
| Award | APRE | Aprea Therapeutics, Inc. | |
| Award | APRE | Aprea Therapeutics, Inc. | |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.